June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
A Novel Model of Tissue Contraction and Inflammation In Fibrosis After Glaucoma Filtration Surgery
Author Affiliations & Notes
  • Garima Sharma
    Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Hanieh Khalili
    Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Ashkan Khalili
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Steve Brocchini
    Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Maryse Bailly
    Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom
  • Peng Tee Khaw
    NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships Garima Sharma, None; Hanieh Khalili, None; Ashkan Khalili, None; Steve Brocchini, None; Maryse Bailly, None; Peng Khaw, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 927. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Garima Sharma, Hanieh Khalili, Ashkan Khalili, Steve Brocchini, Maryse Bailly, Peng Tee Khaw; A Novel Model of Tissue Contraction and Inflammation In Fibrosis After Glaucoma Filtration Surgery. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):927.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Fibrosis plays a part in almost all blinding diseases and underlies treatment failure in many surgical procedures including glaucoma filtration surgery. Developing better medicines to modulate wound healing is challenging as in vivo fibrosis involves both inflammation and fibroblast mediated tissue contraction. Clinically, the presence of significant inflammation after glaucoma surgery indicates a poor prognosis, and scarring occurs even with higher concentrations of Mitomycin-c (MMC) (0.5 mg/ml), necessitating MMC concentrations up to 1.0 mg/ml to overcome fibrosis in these cases. We developed a novel in vitro model incorporating both aspects of fibrosis. We characterised the model and studied the effect of different doses of MMC on fibroblast contraction with or without inflammatory cells.

 
Methods
 

The U937 monocyte-like human cell line was differentiated into macrophage-like cells using phorbol 12-myristate 13-acetate (PMA). Human Tenon’s capsule fibroblasts (HTF), untreated and treated with different doses of MMC for 5 minutes, were co-cultured with macrophages in three-dimensional collagen gels. Contraction was measured using digital photography. Gelatin zymography was used to measure matrix metalloproteinase (MMP) activity.

 
Results
 

Co-culture of fibroblasts and macrophages resulted in a significant increase in collagen gel contraction. Both fibroblast protrusive activity and expression of MMP 2 and 9 were increased, compared to HTFs or macrophages alone (Fig. 1). When HTFs were treated with low doses of MMC (0.01 and 0.1 mg/ml), the inflammatory stimulus provided by macrophages was able to overcome the inhibitory effect of MMC by day 4 (Fig. 2). High dose MMC (1 mg/ml) was required to completely inhibit contraction in the co-culture model.

 
Conclusions
 

This new co-culture model for tissue contraction introduces the inflammatory element found in scarring in vivo. Higher doses of MMC are required to overcome the extra stimulatory effects of inflammatory cells. This has implications for dosing in highly inflamed eyes and this novel model may be useful in screening different combinations of anti-scarring therapies.  

 
Fig. 1. Increased expression of active MMP2 and MMP9 in co-culture at day 3 compared with HTF and macrophages alone.
 
Fig. 1. Increased expression of active MMP2 and MMP9 in co-culture at day 3 compared with HTF and macrophages alone.
 
 
Fig. 2. Higher dose of MMC (1mg/ml) is required to inhibit contraction in fibroblasts when co-cultured with macrophages. n=3, * p<0.05<br />
 
Fig. 2. Higher dose of MMC (1mg/ml) is required to inhibit contraction in fibroblasts when co-cultured with macrophages. n=3, * p<0.05<br />

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×